Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone

Journal of Clinical Investigation

Volumn 114, Issue 9, 2004, Pages 1281-1289

  Wilson Fritch, Leanne ^a   Nicoloro, Sarah ^a   Chouinard, My ^a   Lazar, Mitchell A ^b   Chui, Patricia C ^b   Leszyk, John ^a   Straubhaar, Juerg ^a   Czech, Michael P ^a   Corvera, Silvia ^a,c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Program in Molecular Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL PROTEIN; PALMITIC ACID; ROSIGLITAZONE; TRIACYLGLYCEROL; 2,4 THIAZOLIDINEDIONE DERIVATIVE; CHAPERONIN; COMPLEMENTARY RNA; FATTY ACID; INSULIN; MESSENGER RNA; OXYGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; VASODILATOR AGENT;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; DRUG MECHANISM; ENERGY; ENERGY EXPENDITURE; GENETIC TRANSCRIPTION; HOMEOSTASIS; IN VIVO STUDY; INSULIN SENSITIVITY; LIPID METABOLISM; MITOCHONDRION; MOUSE; NONHUMAN; OBESITY; OXIDATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SATIETY; WHITE ADIPOSE TISSUE; ADIPOCYTE; ANIMAL; C57BL MOUSE; CELL STRAIN 3T3; CHEMISTRY; CYTOLOGY; DNA MICROARRAY; FLUORESCENCE MICROSCOPY; GLUCOSE BLOOD LEVEL; MASS SPECTROMETRY; METABOLISM; MOUSE MUTANT; NORTHERN BLOTTING; PATHOLOGY; TIME; TRANSGENIC MOUSE; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CHAPERONIN 60; FATTY ACIDS; INSULIN; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; MICE, OBESE; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; MITOCHONDRIA; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXYGEN; PALMITIC ACID; PPAR GAMMA; RNA, COMPLEMENTARY; RNA, MESSENGER; THIAZOLIDINEDIONES; TIME FACTORS; VASODILATOR AGENTS;

EID: 85047689659     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI21752     Document Type: Article

References (32)

1. Argyropoulos, G., and Harper, M.E. 2002. Uncoupling proteins and thermoregulation. J. Appl. Physiol. 92:2187-2198.
2. Cannon, B., and Nedergaard, J. 2004. Brown adipose tissue: function and physiological significance. Physiol. Rev. 84:277-359.
3. Rajala, M.W., and Scherer, P.E. 2003. Minireview: the adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology. 144:3765-3773.
4. Friedman, J.M. 2002. The function of leptin in nutrition, weight, and physiology. Nutr. Rev. 60:S1-S14; discussion S68-S84, S85-S17.
5. Wilson-Fritch, L., et al. 2003. Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol. Cell. Biol. 23:1085-1094.
6. Olswang, Y., et al. 2002. A mutation in the peroxisome proliferator-activated receptor gamma-binding site in the gene for the cytosolic form of phosphoenolpytuvate carboxykinase reduces adipose tissue size and fat content in mice. Proc. Natl. Acad. Sci. U. S. A. 99:625-630.
7. Franckhauser, S., et al. 2002. Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance. Diabetes. 51:624-630.
8. Okuno, A., et al. 1998. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J. Clin. Invest. 101:1354-1361.
9. Zhou, Z., et al. 2003. Cidea-deficient mice have lean phenotype and are resistant to obesity. Nat. Genet. 35:49-56.
10. van der Leij, F.R., et al. 2002. Structural and functional genomics of the CPT1B gene for muscle-type carnitine palmitoyltransferase I in mammals. J. Biol. Chem. 277:26994-27005.
11. Brown, N.F., et al. 1997. Mouse white adipocytes and 3T3-L1 cells display an anomalous pattern of carnitine palmitoyltransferase (CPT) I isoform expression during differentiation. Inter-tissue and inter-species expression of CPT I and CPT II enzymes. Biochem. J. 327:225-231.
12. White, R.A., Dowler, L.L., Angeloni, S.V., and Koeller, D.M. 1996. Assignment of Etfdh, Etfb, and Etfa to chromosomes 3, 7, and 13: the mouse homologs of genes responsible for glutaric acidemia type II in human. Genomics. 33:131-134.
13. Stumvoll, M. 2003. Thiazolidinediones-some recent developments. Exp. Opin. Investig. Drugs. 12:1179-1187.
14. Viberti, G.C. 2003. Rosiglitazone: potential beneficial impact on cardiovascular disease. Int. J. Clin. Pract. 57:128-134.
15. Wang, T., Zang, Y., Ling, W., Corkey, B.E., and Guo, W. 2003. Metabolic partitioning of endogenous fatty acid in adipocytes. Obes. Res. 11:880-887.
16. Reshef, L., et al. 2003. Glyceroneogenesis and the triglyceride/fatty acid cycle. J. Biol. Chem. 278:30413-30416.
17. Orci, L., et al. 2004. Rapid transformation of white adipocytes into fat-oxidizing machines. Proc. Natl. Acad. Sci. U. S. A. 101:2058-2063.
18. Watkins, S.M., Reifsnyder, P.R., Pan, H.J., German, J.B., and Leiter, E.H. 2002. Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone. J. Lipid Res. 43:1809-1817.
19. Akazawa, S., Sun, F., Ito, M., Kawasaki, E., and Eguchi, K. 2000. Efficacy of troglitazone on body fat distribution in type 2 diabetes. Diabetes Care. 23:1067-1071.
20. Kelly, I.E., Han, T.S., Walsh, K., and Lean, M.E. 1999. Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes. Diabetes Care. 22:288-293.
21. Miyazaki, Y., et al. 2002. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J. Clin. Endocrinol. Metab. 87:2784-2791.
22. Nakamura, T., et al. 2001. Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation-double-blind placebo-controlled trial. Diabetes Res. Clin. Pract. 54:181-190.
23. Virtanen, K.A., et al. 2003. Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects. Diabetes. 52:283-290.
24. Yoshida, Y., et al. 2002. A peroxisome proliferator-activated receptor gamma agonist influenced daily profile of energy expenditure in genetically obese diabetic rats. Jpn. J. Pharmacol 88:279-284.
25. Mootha, V.K., et al. 2003. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34:267-273.
26. Patti, M.E., et al. 2003. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc. Nad. Acad. Sci. U. S. A. 100:8466-8471.
27. Petersen, K.F., et al. 2003. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science. 300:1140-1142.
28. Kelly, D.P., and Scarpulla, R.C. 2004. Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev. 18:357-368.
29. Wu, Z., et al. 1999. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell. 98:115-124.
30. Puigserver, P., et al. 1998. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92:829-839.
31. Rossmeisl, M., et al. 2002. Expression of the uncoupling protein 1 from the aP2 gene promoter stimulates mitochondrial biogenesis in unilocular adipocytes in vivo. Eur. J. Biochem. 269:19-28.
32. Tiraby, C., et al. 2003. Acquirement of brown fat cell features by human white adipocytes. J. Biol. Chem. 278:33370-33376.